Upstate Active Clinical Trials

Study Title:

NRG-CC008: A NON-RANDOMIZED PROSPECTIVE CLINICAL TRIAL COMPARING THE NON-INFERIORITY OF SALPINGECTOMY TO SALPINGO-OOPHORECTOMY TO REDUCE THE RISK OF OVARIAN CANCER AMONG BRCA1 CARRIERS [SOROCk]

What is the purpose of the study? (in Layman's terms, please describe the study)

To compare the non-inferiority of bilateral salpingectomy (BLS) with delayed oophorectomy to bilateral salpingo-oophorectomy (BSO) to reduce the risk of ovarian cancer among women with deleterious BRCA1 germline mutations.

Upstate Institutional Review Board (IRB) Number:

1665818

Study/Protocol ID:

NRG-CC008

Study Phase:

NA

Patient Age Group:

Adults

Principal Investigator:

Mary J Cunningham, MD

What is involved if I participate?

• How long is the study?
  5 years
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  Ca-125, Transvaginal ultrasound, and misc. blood test.

Where will the study take place?

The Cancer Center - all procedures
Madison Irving - all procedures

Other Information:

The main purpose of this study is to demonstrate the non-inferiority of BLS compared to BSO to reduce the incidence of ovarian cancer among deleterious germline BRCA1 mutation carriers.

ClinicalTrials.Gov ID:

NCT04251052

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Sonia Masood
Phone: 315-464-8232
Email: [email protected]

Return to Previous Page || Search Again